Top Sell
Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Agenus Inc. | 4 | 2 | 0 | 0 | €0.41 | €37.02 | 8846.834% |
Aspira Womens Health Inc. | 1 | 1 | 0 | 0 | €0.64 | €4.99 | 680.063% |
Atara Biotherapeutics Inc. | 1 | 2 | 0 | 0 | €0.37 | - | - |
Bellicum Pharmaceuticals Inc. | 0 | 10 | 0 | 0 | €0.064 | - | - |
Biofrontera AG | 0 | 1 | 0 | 0 | €0.33 | - | - |
B.R.A.I.N. Biotechnology Research and Information Network AG | 0 | 1 | 0 | 0 | €1.49 | - | - |
Cara Therapeutics Inc. | 10 | 7 | 0 | 2 | €0.25 | €4.61 | 1738.566% |
Carbylan Therapeutics Inc | 0 | 1 | 0 | 0 | €9.70 | - | - |
Coherus Bioscien. | 0 | 2 | 0 | 0 | €1.01 | - | - |
Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.05 | €50.00 | 4675.549% |
Edap Tms S.A. ADR | 5 | 2 | 1 | 1 | €2.66 | €17.46 | 556.429% |
Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | €0.99 | - | - |
Fate Therapeutics Inc. | 3 | 3 | 0 | 0 | €3.58 | €7.31 | 104.258% |
Glycomimetics Inc. | 3 | 8 | 0 | 3 | €0.15 | €9.13 | 6088.753% |
Innate Pharma | 0 | 1 | 0 | 0 | €2.03 | - | - |
Karyopharm Therapeutics Inc. | 8 | 1 | 0 | 0 | €0.66 | €5.49 | 735.169% |
Medigene AG | 1 | 1 | 0 | 0 | €1.06 | - | - |
Mevis Medical Sol.na | 0 | 1 | 0 | 1 | €23.00 | - | - |
Minerva Neurosciences Inc. | 0 | 12 | 0 | 3 | €2.44 | - | - |
Nevro Corp. | 1 | 4 | 0 | 0 | €5.20 | €21.13 | 306.437% |
Organovo Holdings Inc. | 0 | 10 | 0 | 2 | €0.45 | - | - |
Owens & Minor Inc. | 3 | 3 | 0 | 1 | €14.30 | €20.11 | 40.613% |
Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
Promis Neurosciences Inc. | 0 | 1 | 0 | 0 | €0.94 | €0.80 | -14.894% |
Protalix Biotherapeutics Inc. | 1 | 1 | 0 | 0 | €0.96 | €2.00 | 107.987% |